Recent BRCAPRO Upgrades Significantly Improve Calibration

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2014-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-13-1364PMID 24891549PMCID PMC4119541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Providing access to risk prediction tools via the HL7 XML-formatted risk web service

  2013cited by this paper
• Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO

  2012cited by this paper
• Interpreting incremental value of markers added to risk prediction models.

  2012cited by this paper
• Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.

  2012cited by this paper
• Statistical Applications in Genetics and Molecular Biology BayesMendel : an R Environment for Mendelian Risk Prediction

  2011cited by this paper
• Accuracy of the BRCAPRO model among women with bilateral breast cancer

  2009cited by this paper
• Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

  2009influential reference
• Tailoring BRCAPRO to Asian-Americans.

  2009cited by this paper
• Relation of risk of contralateral breast cancer to the interval since the first primary tumour

  2009cited by this paper
• Identification and Management of Women at High Risk for Hereditary Breast/Ovarian Cancer Syndrome

  2009cited by this paper
• Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction

  2008cited by this paper
• Validity of Models for Predicting BRCA1 and BRCA2 Mutations

  2007influential reference
• Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

  2007influential reference
• Validity of Models for Predicting BRCA1 and BRCA2 Mutations

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007cited by this paper
• ROCR: visualizing classifier performance in R

  2005cited by this paper
• Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

  2004cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Epidemiology of contralateral breast cancer.

  1999cited by this paper
• Genetics of Breast and Ovarian Cancer

  1999cited by this paper
• Cancer,Facts and Figures about.

  year unknowncited by this paper
• Bmc Medical Genetics Incorporating Medical Interventions into Carrier Probability Estimation for Genetic Counseling

  year unknowncited by this paper

• Variant-specific Mendelian Risk Prediction Model

  2023cites this paper
• Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.

  2023cites this paper
• Lack of Salivary Long Non-Coding RNA XIST Expression Is Associated with Increased Risk of Oral Squamous Cell Carcinoma: A Cross-Sectional Study

  2021cites this paper
• A Competing Risks Model with Time Varying Covariates for Estimation of Breast Cancer Risks in BRCA1 Families

  2020cites this paper
• OP-JNCI190195 418..422

  2020cites this paper
• Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.

  2020cites this paper
• Population-based genetic testing for Women's cancer prevention.

  2020cites this paper
• Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer

  2019cites this paper
• A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2

  2019cites this paper
• Breast Cancer Prevention

  2019cites this paper
• BRCA-carrier identification offers opportunities for early-diagnoses, targeted treatment and cancer prevention. We evaluate BRCA-carrier detection rates in General and Ashkenazi-Jewish(AJ) populations across Greater-London and estimate time-to-detection of all identifiable BRCA-carriers. Methods BRC

  2018cites this paper
• Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

  2018cites this paper
• Mutations in context: implications of BRCA testing in diverse populations

  2017cites this paper
• Adaptation of the Genetic Risk Prediction Model BRCAPRO for Primary Care Settings

  2017cites this paper
• Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer

  2017cites this paper
• Uncertainty quantification in breast cancer risk prediction models using self-reported family health history

  2017cites this paper
• Simpson's paradox in the integrated discrimination improvement

  2017cites this paper
• Risk Assessment for Breast Cancer

  2017cites this paper
• A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital

  2016cites this paper
• Supplementary Issue: Computer Simulation, Bioinformatics, and Statistical Analysis of Cancer Data and Processes

  2015cites this paper
• Breast Cancer Risks and Risk Prediction Models

  2015cites this paper
• Familiärer Brustkrebs – empirische Erkrankungsrisiken und Risikoberechnungsmodelle

  2015cites this paper
• Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry

  2015cites this paper
• Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO

  2015cites this paper
• Breast Cancer Prevention

  2014cites this paper